The diagnosis is based on an overall assessment ... Hereditary spherocytosis shares similar features with hemolytic anemia. This is a form of anemia in which red blood cells are destroyed faster ...

NX-5948 assigned the nonproprietary name "bexobrutideg"U.S. FDA Orphan Drug Designation granted to bexobrutideg for the treatment of Waldenström macroglobulinemiaAchieved $7M in milestones and a $15M ...

Vanrafia reduces proteinuria in adults with primary immunoglobulin A nephropathy (IgAN). It has a wholesale acquisition cost of $162,500 annually.

The US FDA has granted accelerated approval to atrasentan (Vanrafia) for reducing proteinuria in adults with primary ...

CONCLUSIONS Autoimmune hemolytic anemia is a rare adverse effect of immunotherapy, which can be life-threatening without prompt recognition and appropriate management. This case also shows that this ...

Early signs of hemolytic disease of the fetus and newborn (HDFN) can now be detected by 10 weeks, which could lead to better outcomes.

Considerable variability exists in the clinical presentations of pulmonary arterial hypertension (PAH). Greater understanding of the comorbidities observed in Chinese patients with PAH is urgently ...

Of these tests, Hgb, reticulocyte, and bilirubin tests not only play a central role in the diagnosis of spherocytosis but also help describe the severity of the disease. Hereditary spherocytosis ...

Learn about the treatments currently available for HDFN as well as the only therapy in development for this rare disease.